Diaceutics PLC (DXRX) — Capital Reinvestment Ratio
Latest as of June 2025:
0.07x
Diaceutics PLC (DXRX) has a Capital Reinvestment Ratio of 0.07x as of June 2025, meaning it reinvests 0% of its operating cash flow (GBX800.00K) in capital expenditures (GBX55.00K). See Diaceutics PLC free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.07x
Capex / Operating Cash Flow
Operating Cash Flow
GBX800.00K
GBX
Capital Expenditures
GBX55.00K
GBX
Data as of
Jun 2025
Most recent filing
Diaceutics PLC Capital Reinvestment Ratio (2016–2024)
This chart tracks Diaceutics PLC's Capital Reinvestment Ratio across 7 annual periods.
Annual Capital Reinvestment Ratio for Diaceutics PLC (2016–2024)
Year-by-year Capital Reinvestment Ratio for Diaceutics PLC from 2016 to 2024. For live market cap and broader valuation context, see DXRX market cap overview.
| Year | Reinvestment Ratio | Operating CF (GBX) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 7.12x | GBX651.00K | GBX4.63 Million | ▲ +92.1% |
| 2023 | 3.70x | GBX1.31 Million | GBX4.86 Million | ▲ +287.5% |
| 2022 | 0.96x | GBX5.10 Million | GBX4.87 Million | ▼ -90.3% |
| 2021 | 9.83x | GBX570.00K | GBX5.60 Million | ▼ -60.5% |
| 2020 | 24.88x | GBX253.00K | GBX6.29 Million | ▲ +13390.3% |
| 2017 | 0.18x | GBX1.53 Million | GBX282.92K | ▲ +328.1% |
| 2016 | 0.04x | GBX674.01K | GBX29.03K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow